Skip to main content

December 2016 - FRMC

News
01/02/2017
Dave Muoio
As public outcry over high drug prices has reached a fever pitch, drugmakers, PBMs, and payers have become caught up in a blame game over who is really responsible for the high prices of insulin products.
As public outcry over high drug prices has reached a fever pitch, drugmakers, PBMs, and payers have become caught up in a blame game over who is really responsible for the high prices of insulin products.
As public outcry over high drug...
01/02/2017
First Report Managed Care
News
12/31/2016
Dean Celia
The nonsurgical option for candidates for surgical aortic valve replacement (SAVR) is transcatheter aortic valve replacement (TAVR) – but it comes at a cost.
The nonsurgical option for candidates for surgical aortic valve replacement (SAVR) is transcatheter aortic valve replacement (TAVR) – but it comes at a cost.
The nonsurgical option for...
12/31/2016
First Report Managed Care
News
12/30/2016
Dean Celia
First Report Managed Care spoke to government insiders and managed care experts to tease out the complexities of the path to repeal, replace, or restructure the ACA.
First Report Managed Care spoke to government insiders and managed care experts to tease out the complexities of the path to repeal, replace, or restructure the ACA.
First Report Managed Care spoke...
12/30/2016
First Report Managed Care
News Connection
12/19/2016
Study showed that Simponi Aria (golimumab; Janssen), an anti-tumor necrosis factor (TNF)-alpha therapy, was effective in treating active ankylosing spondylitis.
Study showed that Simponi Aria (golimumab; Janssen), an anti-tumor necrosis factor (TNF)-alpha therapy, was effective in treating active ankylosing spondylitis.
Study showed that Simponi Aria...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
New data suggests Bosulif (bosutinib; Pfizer Inc) is superior to imatinib as a treatment for Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).
New data suggests Bosulif (bosutinib; Pfizer Inc) is superior to imatinib as a treatment for Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).
New data suggests Bosulif...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
Opdivo (nivolumab; Bristol-Myers Squibb) was found to increase survival of patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Opdivo (nivolumab; Bristol-Myers Squibb) was found to increase survival of patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Opdivo (nivolumab; Bristol-Myers...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
The safety of patients with dementia who received prescriptions through both the Veterans Affairs system and through Medicare Part D was compromised. 
The safety of patients with dementia who received prescriptions through both the Veterans Affairs system and through Medicare Part D was compromised. 
The safety of patients with...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
The American Society of Clinical Oncology (ASCO) recently published criteria for the development of high-quality clinical pathways in oncology to ensure that all clinical pathways used in oncology promote high-quality patient care. 
The American Society of Clinical Oncology (ASCO) recently published criteria for the development of high-quality clinical pathways in oncology to ensure that all clinical pathways used in oncology promote high-quality patient care. 
The American Society of Clinical...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
A federal appeals court has granted a request by House Republicans to delay the Obama administration’s appeal of a key Affordable Care Act (ACA) ruling until after President-elect Donald Trump has taken office.
A federal appeals court has granted a request by House Republicans to delay the Obama administration’s appeal of a key Affordable Care Act (ACA) ruling until after President-elect Donald Trump has taken office.
A federal appeals court has...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
According to a recent announcement, President-elect Donald Trump has nominated Rep Tom Price, MD (R-GA)—a staunch opponent of the ACA—for secretary of the Department of Health and Human Services (HHS). Trump has also nominated Seema Verma—a...
According to a recent announcement, President-elect Donald Trump has nominated Rep Tom Price, MD (R-GA)—a staunch opponent of the ACA—for secretary of the Department of Health and Human Services (HHS). Trump has also nominated Seema Verma—a...
According to a recent...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
After easily passing the US House of Representatives and a subsequent vote to end debate on the proposal in the US Senate, the 21st Century Cures Act seemed poised to pass the Senate at press time and move forward to President Obama to sign...
After easily passing the US House of Representatives and a subsequent vote to end debate on the proposal in the US Senate, the 21st Century Cures Act seemed poised to pass the Senate at press time and move forward to President Obama to sign...
After easily passing the US...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
According to a recent analysis, enrollment in Medicaid programs provided through managed care organizations increased significantly between June 2015 and June 2016.
According to a recent analysis, enrollment in Medicaid programs provided through managed care organizations increased significantly between June 2015 and June 2016.
According to a recent analysis,...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
A recent report revealed global drug spending on medicines is expected to surpass $1 trillion by the year 2021, however, over the next five years, spending is expected to slow from previous records. 
A recent report revealed global drug spending on medicines is expected to surpass $1 trillion by the year 2021, however, over the next five years, spending is expected to slow from previous records. 
A recent report revealed global...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
In an effort to combat controversy over climbing prices, and hoping to simplify a complex system, Novo Nordisk has detailed a series of steps to ensure a “positive impact on affordability for patients,” according to a recent press release.
In an effort to combat controversy over climbing prices, and hoping to simplify a complex system, Novo Nordisk has detailed a series of steps to ensure a “positive impact on affordability for patients,” according to a recent press release.
In an effort to combat...
12/19/2016
First Report Managed Care
12/19/2016
Jill Sederstorm
With stakeholders clamoring for a way to quell rising drug prices, more pharmacy benefit managers are exploring value-based drug pricing models.
With stakeholders clamoring for a way to quell rising drug prices, more pharmacy benefit managers are exploring value-based drug pricing models.
With stakeholders clamoring for...
12/19/2016
First Report Managed Care
12/19/2016
Dean Celia
President-elect Donald J Trump has declared that the Trump Administration will be asking Congress to either amend Obamacare or repeal and replace it. 
President-elect Donald J Trump has declared that the Trump Administration will be asking Congress to either amend Obamacare or repeal and replace it. 
President-elect Donald J Trump...
12/19/2016
First Report Managed Care
Formulary Frontlines®
12/19/2016
Eileen Koutnik-Fotopoulos
The clinical and economic burden of chronic obstructive pulmonary disease is compounded by underdiagnosis and undertreatment.
The clinical and economic burden of chronic obstructive pulmonary disease is compounded by underdiagnosis and undertreatment.
The clinical and economic burden...
12/19/2016
First Report Managed Care
Department
12/19/2016
Using antibiotic prophylaxis to prevent ineffective endocarditis is cost-effective for patients at risk and especially cost-effective among patients with a high risk, according to a presentation at the American Heart Association 2016...
Using antibiotic prophylaxis to prevent ineffective endocarditis is cost-effective for patients at risk and especially cost-effective among patients with a high risk, according to a presentation at the American Heart Association 2016...
Using antibiotic prophylaxis to...
12/19/2016
First Report Managed Care
Department
12/19/2016
According to a study, use of Eliquis was associated with lower costs and use of health care resources among elderly patients with nonvalvular atrial fibrillation.
According to a study, use of Eliquis was associated with lower costs and use of health care resources among elderly patients with nonvalvular atrial fibrillation.
According to a study, use of...
12/19/2016
First Report Managed Care
Department
12/19/2016
Results showed that sarilumab was superior to Humira (adalimumab) as monotherapy in patients with active rheumatoid arthritis.
Results showed that sarilumab was superior to Humira (adalimumab) as monotherapy in patients with active rheumatoid arthritis.
Results showed that sarilumab...
12/19/2016
First Report Managed Care
Department
12/19/2016
For patients, satisfaction with biosimilar medications is generally no different than satisfaction with bio-originator medications. 
For patients, satisfaction with biosimilar medications is generally no different than satisfaction with bio-originator medications. 
For patients, satisfaction with...
12/19/2016
First Report Managed Care
Department
12/19/2016
Kimberly White opened the NAMCP 2016 Fall Managed Care Forum with how physicians and payers can collaborate to improve care and lower costs. 
Kimberly White opened the NAMCP 2016 Fall Managed Care Forum with how physicians and payers can collaborate to improve care and lower costs. 
Kimberly White opened the NAMCP...
12/19/2016
First Report Managed Care
Department
12/19/2016
David Lang, MD presented on the newest developments in asthma treatment during the NAMCP 2016 Fall Managed Care Forum.
David Lang, MD presented on the newest developments in asthma treatment during the NAMCP 2016 Fall Managed Care Forum.
David Lang, MD presented on the...
12/19/2016
First Report Managed Care
Department
12/19/2016
During an NAMCP 2016 Fall Managed Care Forum presentation, Joel W Neal, MD, PhD, discussed how to integrate novel personalized therapies, such as immunotherapy, into non-small cell lung cancer (NSCLC) treatment plans to optimize outcomes. 
During an NAMCP 2016 Fall Managed Care Forum presentation, Joel W Neal, MD, PhD, discussed how to integrate novel personalized therapies, such as immunotherapy, into non-small cell lung cancer (NSCLC) treatment plans to optimize outcomes. 
During an NAMCP 2016 Fall...
12/19/2016
First Report Managed Care
Department
12/19/2016
Patients undergoing hematopoietic stem cell transplantation with psychosocial vulnerability are at risk for hospital readmission and increased length of stay.
Patients undergoing hematopoietic stem cell transplantation with psychosocial vulnerability are at risk for hospital readmission and increased length of stay.
Patients undergoing...
12/19/2016
First Report Managed Care
Managed Care Q&A
12/15/2016
David Costill
In this interview with Deborah S Keller, MD, Department of Surgery,  Baylor University Medical Center, Dr Keller discusses cost-effective invasive surgery.
In this interview with Deborah S Keller, MD, Department of Surgery,  Baylor University Medical Center, Dr Keller discusses cost-effective invasive surgery.
In this interview with Deborah S...
12/15/2016
First Report Managed Care